U.S. private equity firm Lone Star has told the Portuguese government that it is likely to sell a 25-30% stake in Novo Banco ...

The company launched the IPO after doubling revenue in 2024, driven by increased oil production from well acquisitions worth ...

Saudi Arabia is experiencing a boom in IPO activity, signaling the liberalization of its economy and a shift away from government-led privatizations that once dominated its investment market. The ...

Book messages went out on Friday afternoon saying the joint lead managers had received firm cornerstone bids and indications ...

Polish medical diagnostics company Diagnostyka on Friday said it priced its initial public offer at 105 zlotys per share, the ...

By raising ₹500-600 crore, this firm aims to strengthen its market position and adapt to evolving global trends.

The company said its current shareholder base is around 29,000 and in order to avoid a situation where its shareholder base increases further ...

The move seeks to leverage the wealth of information available with the ministry of corporate affairs from various statutory ...

Discover key insights from Startup Finance 360°, covering funding, valuation, and financial strategies to help founders build ...

The SGX candidates were earlier keen on US listing but now reconsidering Singapore. Read more at straitstimes.com.

Indian biopharmaceutical firm Biocon is likely to list its key biosimilars business by March 2026 and aims for double-digit share in its core U.S. market for its new launches, a top executive told ...

Dr Agarwal's Health Care is selling its shares in the price band of Rs 382-402 apiece, which could be applied for a minimum ...